Home
IBIO
IBIO News

Latest iBio Inc. (IBIO) News on November 28, 2025

iBio to Participate in the 8th Annual Evercore Healthcare Conference

GlobeNewswire

3 days ago

iBio to Participate in the 8th Annual Evercore Healthcare Conference

iBio, Inc. (IBIO) Reports Q1 Loss

Zacks

15 days ago

iBio, Inc. (IBIO) Reports Q1 Loss

iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update

GlobeNewswire

15 days ago

iBio Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update

iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance

GlobeNewswire

a month ago

iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance

iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

GlobeNewswire

a month ago

iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

MT Newswires

a month ago

Oppenheimer Initiates Coverage on iBio With Outperform Rating, $5 Price Target

iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025

GlobeNewswire

a month ago

iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025

iBio Full Year 2025 Earnings: US$1.75 loss per share (vs US$4.03 loss in FY 2024)

Simply Wall St.

3 months ago

iBio Full Year 2025 Earnings: US$1.75 loss per share (vs US$4.03 loss in FY 2024)

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire

3 months ago

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results

GlobeNewswire

5 months ago

iBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo Results

iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call

GlobeNewswire

5 months ago

iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment

GlobeNewswire

5 months ago

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment

Insider Buyers At iBio Likely Disappointed With 23% Slide

Simply Wall St.

7 months ago

Insider Buyers At iBio Likely Disappointed With 23% Slide

iBio’s First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss and Shows Synergy with GLP-1s in Preclinical Model

GlobeNewswire

7 months ago

iBio’s First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss and Shows Synergy with GLP-1s in Preclinical Model

iBio Reports Fiscal Third Quarter 2025 Financial Results

GlobeNewswire

7 months ago

iBio Reports Fiscal Third Quarter 2025 Financial Results

iBio Raises $6.2 Million Through Warrant Inducement Transaction

GlobeNewswire

7 months ago

iBio Raises $6.2 Million Through Warrant Inducement Transaction

iBio Expands Cardiometabolic and Obesity Pipeline through Licensing of First-in-Class Antibody Targeting Activin E from AstralBio

GlobeNewswire

7 months ago

iBio Expands Cardiometabolic and Obesity Pipeline through Licensing of First-in-Class Antibody Targeting Activin E from AstralBio

iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline

GlobeNewswire

8 months ago

iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline

iBio to Begin Trading on the Nasdaq Stock Exchange

GlobeNewswire

9 months ago

iBio to Begin Trading on the Nasdaq Stock Exchange

Is Ibio, Inc. (IBIO) Among Stocks Insiders Are Buying This Year?

Insider Monkey

9 months ago

Is Ibio, Inc. (IBIO) Among Stocks Insiders Are Buying This Year?

iBio Reports Fiscal Second Quarter 2025 Financial Results

GlobeNewswire

10 months ago

iBio Reports Fiscal Second Quarter 2025 Financial Results

iBio Announces New Investments from Board Members and Officers

GlobeNewswire

10 months ago

iBio Announces New Investments from Board Members and Officers

iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio

GlobeNewswire

a year ago

iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio

iBio Expands Pipeline with New Antibody Agreement

TipRanks

a year ago

iBio Expands Pipeline with New Antibody Agreement

Nano-Cap iBio Expands Obesity Program With New Antibody Using In-Licensed Platform

Benzinga

a year ago

Nano-Cap iBio Expands Obesity Program With New Antibody Using In-Licensed Platform

iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio

GlobeNewswire

a year ago

iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio

iBio Strengthens Board with Appointment of Two New Independent Directors

GlobeNewswire

a year ago

iBio Strengthens Board with Appointment of Two New Independent Directors

iBio Reports Fiscal First Quarter 2025 Financial Results

GlobeNewswire

a year ago

iBio Reports Fiscal First Quarter 2025 Financial Results

iBio and AstralBio Provide Update on Myostatin Program for Obesity

GlobeNewswire

a year ago

iBio and AstralBio Provide Update on Myostatin Program for Obesity

iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire

a year ago

iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update

iBio to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

iBio to Participate in Upcoming Investor Conferences

iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development

GlobeNewswire

a year ago

iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development

iBio Closes Sale of Manufacturing Facility in Texas

GlobeNewswire

a year ago

iBio Closes Sale of Manufacturing Facility in Texas

iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

2 years ago

iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update

iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases

GlobeNewswire

2 years ago

iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases

iBio Announces $15.0 Million Private Placement

GlobeNewswire

2 years ago

iBio Announces $15.0 Million Private Placement

12 Best Biotech Penny Stocks to Invest In

Insider Monkey

2 years ago

12 Best Biotech Penny Stocks to Invest In

iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka

GlobeNewswire

2 years ago

iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

GlobeNewswire

2 years ago

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

Two New Knightscope Security Robots Now Protecting Houston Property

Business Wire

2 years ago

Two New Knightscope Security Robots Now Protecting Houston Property

Syra Health Receives a Contract Extension from Indiana Veterans' Home

PR Newswire

2 years ago

Syra Health Receives a Contract Extension from Indiana Veterans' Home

Agri Supply Chooses Bridgeline’s AI-Powered Smart Search

GlobeNewswire

2 years ago

Agri Supply Chooses Bridgeline’s AI-Powered Smart Search

Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire

2 years ago

Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

GlobeNewswire

2 years ago

Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

NAVIGATING TOMORROW: Japan Airlines Cargo Chooses WebCargo for Global Digital Expansion

PR Newswire

2 years ago

NAVIGATING TOMORROW: Japan Airlines Cargo Chooses WebCargo for Global Digital Expansion

Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

GlobeNewswire

2 years ago

Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

GDC’s Exploring the Evolution of AI Influencers: From TikTok Storytelling to Instagram Allure

GlobeNewswire

2 years ago

GDC’s Exploring the Evolution of AI Influencers: From TikTok Storytelling to Instagram Allure

5E Advanced Materials Selects EPC Contractor Fluor Corporation For Process Engineering Work on FEL-2

GlobeNewswire

2 years ago

5E Advanced Materials Selects EPC Contractor Fluor Corporation For Process Engineering Work on FEL-2

Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan

PR Newswire

2 years ago

Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan

7 Cyclical Penny Stocks Best Positioned for 2024

InvestorPlace

2 years ago

7 Cyclical Penny Stocks Best Positioned for 2024

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

GlobeNewswire

2 years ago

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

1,300 E-JEEPNEY ORDER COMMITMENTS IN THE PHILIPPINES FOR TEMBO FRANCISCO MOTORS JOINT VENTURE

PR Newswire

2 years ago

1,300 E-JEEPNEY ORDER COMMITMENTS IN THE PHILIPPINES FOR TEMBO FRANCISCO MOTORS JOINT VENTURE

GlobeNewswire

2 years ago

VivoPower International PLC Reports Unaudited Preliminary Results for the Six Months Ended December 31, 2023

3 Penny Stocks AI Predicts Will Skyrocket 10,000%

InvestorPlace

2 years ago

3 Penny Stocks AI Predicts Will Skyrocket 10,000%

Jewett-Cameron Announces 1st Quarter Financial Results

PR Newswire

2 years ago

Jewett-Cameron Announces 1st Quarter Financial Results

iBio Announces Participation in 23rd Annual PepTalk Conference

GlobeNewswire

2 years ago

iBio Announces Participation in 23rd Annual PepTalk Conference

Freightos Announces Record Transactions for Fourth Quarter of 2023 and Date of Fourth Quarter and Full Year Earnings Release

PR Newswire

2 years ago

Freightos Announces Record Transactions for Fourth Quarter of 2023 and Date of Fourth Quarter and Full Year Earnings Release

Beam Global Receives $7.4M Order from the U.S. Army for 88 Off-Grid EV ARC™ Electric Vehicle Charging Systems

GlobeNewswire

2 years ago

Beam Global Receives $7.4M Order from the U.S. Army for 88 Off-Grid EV ARC™ Electric Vehicle Charging Systems

5E Advanced Materials Announces Stockholder Approval of Proposed Out of Court Restructuring

GlobeNewswire

2 years ago

5E Advanced Materials Announces Stockholder Approval of Proposed Out of Court Restructuring

Sunrise New Energy Files for China Patent Award, the Highest Honor in Intellectual Property Rights

GlobeNewswire

2 years ago

Sunrise New Energy Files for China Patent Award, the Highest Honor in Intellectual Property Rights

GlobeNewswire

2 years ago

VIVOPOWER ANNOUNCES FOLLOW-ON STRATEGIC DIRECT INVESTMENT IN TEMBO AT US$120M PRE-MONEY VALUATION

Newsfile

2 years ago

PetVivo Holdings, Inc. Invites You to Join Us at The Microcap Conference

Shipment rates soar 4x after Red Sea attacks: CEO

Yahoo Finance Video

2 years ago

Shipment rates soar 4x after Red Sea attacks: CEO

Akerna Announces Special Meeting Date to Vote on Merger with Gryphon Digital Mining, Inc.; Effectiveness of Registration Statement on Form S-4 in Connection with Merger

GlobeNewswire

2 years ago

Akerna Announces Special Meeting Date to Vote on Merger with Gryphon Digital Mining, Inc.; Effectiveness of Registration Statement on Form S-4 in Connection with Merger

PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA

GlobeNewswire

2 years ago

PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA

Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit

GlobeNewswire

2 years ago

Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit

Trust Stamp ® Announces that Forty-Five customers started or completed integration with the Company’s Orchestration Layer by the end of 2023

GlobeNewswire

2 years ago

Trust Stamp ® Announces that Forty-Five customers started or completed integration with the Company’s Orchestration Layer by the end of 2023

Trust Stamp announces a patent filing for a groundbreaking AI-powered facial recognition technology

GlobeNewswire

2 years ago

Trust Stamp announces a patent filing for a groundbreaking AI-powered facial recognition technology

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

GlobeNewswire

2 years ago

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

GlobeNewswire

2 years ago

DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

GameSquare Completes the Sale of Its Non-Core Radio Business Assets

ACCESSWIRE

2 years ago

GameSquare Completes the Sale of Its Non-Core Radio Business Assets

EUDA Health Holdings Second Quarter 2023 Earnings: US$0.28 loss per share (vs US$1.86 loss in 2Q 2022)

Simply Wall St.

2 years ago

EUDA Health Holdings Second Quarter 2023 Earnings: US$0.28 loss per share (vs US$1.86 loss in 2Q 2022)

Exela Technologies Announces Adjournment of Annual Meeting until January 26, 2024

GlobeNewswire

2 years ago

Exela Technologies Announces Adjournment of Annual Meeting until January 26, 2024

Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

2 years ago

Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

InvestorPlace

2 years ago

Why Is Cingulate (CING) Stock Up 160% Today?

Investing.com

2 years ago

Midday movers: Microsoft, AMD, Boeing, and more

iBio Amends and Extends Maturity of Credit Agreement

GlobeNewswire

2 years ago

iBio Amends and Extends Maturity of Credit Agreement

Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on December 29, 2023 at 10:00 a.m. Eastern Time

GlobeNewswire

2 years ago

Exela Technologies Reminds Stockholders to Cast Their Vote for Upcoming Annual Meeting of Stockholders to be held on December 29, 2023 at 10:00 a.m. Eastern Time

GD Culture Group Unveils its Innovative Marketing Approach, One Story at a Time

GlobeNewswire

2 years ago

GD Culture Group Unveils its Innovative Marketing Approach, One Story at a Time

Gaming Icon Tyler "Ninja" Blevins Announces Live NYE Special Sponsored by Domino's Pizza

ACCESSWIRE

2 years ago

Gaming Icon Tyler "Ninja" Blevins Announces Live NYE Special Sponsored by Domino's Pizza

CEO INCREASE IN INDIVIDUAL SHAREHOLDING TO 11.2%

GlobeNewswire

2 years ago

CEO INCREASE IN INDIVIDUAL SHAREHOLDING TO 11.2%

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

GlobeNewswire

2 years ago

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

Lixiang Education Announces Plan to Implement ADS Ratio Change

PR Newswire

2 years ago

Lixiang Education Announces Plan to Implement ADS Ratio Change

HUB Secures Prestigious Position as Prime Vendor in Major Deal with Top-Tier Israeli Defense Contractor for Advanced Real-Time Battle Computing Solutions

GlobeNewswire

2 years ago

HUB Secures Prestigious Position as Prime Vendor in Major Deal with Top-Tier Israeli Defense Contractor for Advanced Real-Time Battle Computing Solutions

Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger

ACCESSWIRE

2 years ago

Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger

Who Controls HUB Cyber Security Ltd. (NASDAQ:HUBC)?

Simply Wall St.

2 years ago

Who Controls HUB Cyber Security Ltd. (NASDAQ:HUBC)?

Exela Technologies Recognized as Emerging Solution in FAO Hackett Value Matrix™

GlobeNewswire

2 years ago

Exela Technologies Recognized as Emerging Solution in FAO Hackett Value Matrix™

Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose

GlobeNewswire

2 years ago

Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose

HUB Announces Reverse Share Split

GlobeNewswire

2 years ago

HUB Announces Reverse Share Split

TechPrecision Corp. Provides Select Unaudited FY2023 Financial Information for Votaw Precision Technologies, Inc.

ACCESSWIRE

2 years ago

TechPrecision Corp. Provides Select Unaudited FY2023 Financial Information for Votaw Precision Technologies, Inc.

Secure Medical Chooses Edgio for Fast, Secure Delivery of Telehealth Services

Business Wire

2 years ago

Secure Medical Chooses Edgio for Fast, Secure Delivery of Telehealth Services

Air Industries Group Announces Results for Third Quarter Ended September 30, 2023 and Comments on Business Outlook

Business Wire

2 years ago

Air Industries Group Announces Results for Third Quarter Ended September 30, 2023 and Comments on Business Outlook

Ted Olt succeeds Dana Waterman in key Lee Enterprises role

GlobeNewswire

2 years ago

Ted Olt succeeds Dana Waterman in key Lee Enterprises role

Presidio Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

GlobeNewswire

2 years ago

Presidio Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Presidio Property Trust Declares Fourth-Quarter 2023 Dividend

GlobeNewswire

2 years ago

Presidio Property Trust Declares Fourth-Quarter 2023 Dividend

Movano Health's Women-First Wearable, the Evie Ring, Receives 2024 CES Innovation Award

PR Newswire

2 years ago

Movano Health's Women-First Wearable, the Evie Ring, Receives 2024 CES Innovation Award

iBio, Inc. Announces Pricing of $4.5 Million Public Offering

GlobeNewswire

2 years ago

iBio, Inc. Announces Pricing of $4.5 Million Public Offering

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

GlobeNewswire

2 years ago

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

BowFlex Inc. Announces Receipt of Continued Listing Standard Notice from NYSE

Business Wire

2 years ago

BowFlex Inc. Announces Receipt of Continued Listing Standard Notice from NYSE

Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)

GlobeNewswire

2 years ago

Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)

Share on Social Networks: